Effects of semaglutide and dapagliflozin on natriuretic peptides in type 2 diabetes: a randomized comparative study
Type 2 diabetes (T2D) is associated with a substantially increased risk of heart failure, partly mediated by myocardial stress and neurohormonal activation. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) both improve cardiovascular outcomes in T2D, bu...